Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Regulation of the K-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain.

< BACK TO ARCHIVE


Papers: 19 Sep 2020 - 25 Sep 2020


Animal Studies


2020 Sep 22


Reg Anesth Pain Med


http://www.ncbi.nlm.nih.gov/pubmed/32963077?dopt=Abstract

Regulation of the K-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain.

Authors

Regulation of the K-JNK gap junction signaling pathway by immunomodulator astragaloside IV attenuates neuropathic pain.
Dai W-L, Zhang L, Han L, Yang X, Hu L, Miao C, Song L, Xiao H, Liu J-H, Liu W-T
Reg Anesth Pain Med. 2020 Sep 22.
PMID: 32963077.

Abstract

Gap junctions play a pivotal role in contributing to the formation of astroglial networks and in chronic pain. However, the mechanisms underlying the dysfunction of astroglial gap junctions in chronic pain have not been fully elucidated.
Read This Paper